Diagnostics Lab Automation and Monitoring Solutions Growth Opportunities

Healthcare Diagnostics Lab Automation and Monitoring Solutions Growth Opportunities Updated Research Available

The Intersection of Automation and Digital Data Exchange Unlocks Value for Diagnostics Labs

INDUSTRY
Healthcare

RELEASE DATE
17-Jun-2024
REGION
Global
DELIVERABLE TYPE
Market Research

RESEARCH CODE
PFF5-01-00-00-00
SKU
HC_2024_807
Yes
SHARE

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC_2024_807

Diagnostics Lab Automation and Monitoring Solutions Growth Opportunities
Published on: 17-Jun-2024 | SKU: HC_2024_807

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

The pathology workforce shortage, accuracy concerns, and uneven distribution of prices and resources are persistent challenges for the diagnostics sector.

Lab test results are the foundation of future human health, influencing 70% of clinical decisions. A surge in lab tests’ yearly volume will result from persistent trends, including aging populations, growing non-communicable diseases, early-onset cancers, type 2 diabetes, and other cardiometabolic and neurodegenerative diseases.

In consequence, advancements in digital technology are steadily expanding the availability of lab diagnostic tools beyond traditional medical settings. The popularity of omnichannel experiences across various consumer digital touchpoints and the rise of mobile apps, online aggregator platforms, and self-care trends (for instance, preventive checks) are boosting the year-over-year (YoY) number of digital users of pathology labs. Certain technologies, such as next-generation sequencing, are shaping the high-end specialized test spectrum, including oncology, prenatal, and infectious disease diagnostics.

In this context, a robust business expansion strategy that drives growth while also improving resilience and sustainability is critical for pathology labs looking to expand their business to new markets. Many labs have partnered with in vitro diagnostics vendors to increase access, optimize network organization, and recover lab productivity. These efforts improve test results’ delivery and generate better-oriented test menus that persist throughout economic cycles.

Furthermore, the strategic use of digitization and automation is vital for labs to pivot and grow with changing consumer expectations—improved convenience, affordable pricing, and quicker turnaround times. However, incremental upgrades to legacy equipment and workflows may affect digital transformation maturity. Robotic automation and proactive lab monitoring capable of performing intelligent operations are also entering the sector. With a projected 9.1% CAGR, the lab automation and monitoring solutions industry is a significant inflection point in the diagnostics industry.

Author: Amartya Bose

Revenue Forecast

The revenue estimate for the base year 2023 is $2.50 billion with a CAGR of 9.1% for the study period from 2023 to 2028.

 

 

The Impact of the Top 3 Strategic Imperatives on the Lab Automation and Monitoring Solutions Industry

Transformative Megatrends

Why: 

  • Smart infrastructure demand from diagnostics labs increases due to specific needs, including the need to reduce energy consumption, increase contextual visibility into systems’ performance, generate actionable insights, meet value-based operations, and create safe and standardized workflows. Neglecting this interplay may lead to low-level system integration, increased energy consumption, and higher costs.

Frost Perspective: 

  • As the proliferation of modular systems automates pre- and post-analytical workflows, the future of lab operations will utilize an all-inclusive digital optimization strategy that begins with data, proactive lab monitoring, and flexible automation systems.
  • Navigating the interchange with automated liquid handling, real-time data monitoring, and insights as a service is critical to enabling value-based lab operations, including enhancing operational efficiency, accuracy, and patient care.

Internal Challenges

Why: 

  • Beyond primary experimental data, the lab data sphere includes instrument calibration records, inventory data, environmental data, test protocols, and test results from multiple systems that lack interconnectivity. A fragmented data infrastructure obstructs teams’ proactivity about efficiency and continuous improvement. To mitigate this, labs seek to embrace agility and data-driven growth backed by a variety of hardware, software, and service solutions.

Frost Perspective: 

  • The current data integration approach based on point-to-point connectivity has led to data silos. The data atrophy effect is increasing costs and slowing service scalability potential.
  • Labs will embrace real-time data monitoring, including real-time data exchange and insights from all lab assets, to accelerate lead time and innovation.

 

Innovative Business Models

Why: 

  • The pandemic’s aftermath has evinced the urgency of moving to digitization and automation, which are steadily increasing.
  • Faster remote data access, scalable cloud-based storage, asset monitoring, remote operations, and improved stakeholder collaboration are new battlegrounds for success in the product lifecycle.

Frost Perspective: 

  • An insight-as-a-service model will shift diagnostics labs’ value proposition—which currently revolves around test accuracy, sensitivity, and speed—to value-based lab services organizations armed with remote monitoring and integrated analytics capabilities.
  • Implementing this model through contracts and on-demand businesses will create durable growth throughout economic cycles.

 

Scope of Analysis

  • This analysis examines the global diagnostics lab automation and monitoring industry.
  • Frost & Sullivan has focused on this industry due to its many transformations to meet the demand for cutting-edge technologies and intelligent software tools that promise more intuitiveness and consumer-centricity.
  • Lab automation solutions cover many aspects of lab operations, such as pre- and post-analytical workflows, whereas lab monitoring systems cover an entire facility. These solutions streamline workflows by integrating robotics, instruments, and software.
  • Lab monitoring solutions incorporate sensors, environmental monitoring, facility (asset) monitoring, and compliance monitoring systems to enhance the performance and stability of the lab workflow and maintenance.
  • In conjunction with the Internet of Things (IoT), lab automation and monitoring solutions may enable AI/ML algorithms to identify trends that may otherwise go unnoticed.
  • The industry can be divided into solutions, selected applications, and products and services. This study focuses on lab automation and monitoring systems solutions for revenue estimations and forecast analysis.

Scope

  • Global
  • North America (NA)
  • Europe
  • Middle East and Asia-Pacific (ME & APAC)
  • Rest of the World (ROW)

 

Segmentation

Lab Automation and Monitoring (Solutions)

Automation Systems

  • Microplate handling (robotic arms, stacker, barcode labeler)
  • Liquid handling (liquid handler, microplate washer/reagent dispenser, magnetic bead station, pipetting systems, pipette tips)
  • Lab automation software (scheduling software, control software, protocol software, pipetting software)
  • Other solutions/work cells

Monitoring Systems

  • Sensors
  • Facility monitoring (modular asset management, preventive maintenance, real-time monitoring, alarm notifications)
  • Compliance monitoring (lab data integration and management)
  • Environmental monitoring (tracking temperature, O2, CO2, pressure, humidity, light levels, water spills)
  • Other solutions

Lab Automation and Monitoring (Products and Services)

Hardware

  • Instruments and robotic instruments
  • Sensors
  • Consumables
  • Others

Software

  • Lab automation software
  • Facility monitoring and environmental monitoring
  • Compliance monitoring
  • Others

Services

  • Installation, training, and maintenance
  • Replacement and repairs
  • Technical support
  • Qualification and calibration
  • Remote access to data
  • Remote monitoring and support
  • Storage services
  • Data analytics
  • Other connected services

Lab Automation and Monitoring (Selected Applications)

  • Liquid Handling
  • Sample Management
  • Data Management
  • Data Analytics
  • Remote Monitoring

 

Competitive Environment

Number of Competitors 24 with revenue greater than $2.50 billion
Competitive Factors Technology, precision, service and support efficiency, performance, privacy and security, outcomes
Key End-user Industry Verticals Diagnostics labs
Leading Competitors Beckman Coulter (Danaher), Thermo Fisher Scientific, Agilent Technologies, Eppendorf, Abbott
Revenue Share of Top 5 Competitors (2023) 73%
Other Notable Competitors Bio-Rad Laboratories, Waters Corporation, Siemens Healthineers, Revvity, bioMérieux, Roche Diagnostics, Hamilton, Qiagen
Distribution Structure Original equipment manufacturers and direct sales
Notable Acquisitions and Mergers Bruker acquired Chemspeed, Beckman Coulter bought Labcyte, Waters partnered with Scitaria and invested in Andrew Alliance, Hamilton purchased BioFluidX

 

Key Competitors

  • Eppendorf
  • Roche Diagnostics
  • Abbott
  • Danaher (Beckman Coulter)
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Bio-Rad Laboratories
  • bioMérieux
  • Revity
  • Waters
  • Hudson Robotics
  • Hamilton
  • Gilson
  • Qiagen
  • Abbott
  • Danaher (Beckman Coulter)
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Revity
  • Hudson Robotics
  • Bio-Rad Laboratories
  • Hamilton
  • Waters
  • Gilson
  • Elemental Machines
  • Scitara
  • Opentr0n
  • Data Innovations
  • Eppendorf
  • Roche Diagnostics
  • Siemens Healthineers
  • Inpeco
  • bioMérieux
  • Flow Robotics
  • Gilson
  • Qiagen
  • BGI Genomics
  • Sysmex
  • Yaskawa
  • LTS Health
  • Eppendorf
  • Roche Diagnostics
  • Abbott
  • Danaher (Beckman Coulter)
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Inpeco
  • bioMérieux
  • Revvity
  • Hamilton
  • Gilson
  • Flow Robotics
  • Qiagen
  • Elemental Machines
  • Emerald Cloud Labs
  • Mesa Labs

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Lab Automation and Monitoring Solutions Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Segmentation

Segmentation (continued)

Key Competitors

Key Competitors (continued)

Growth Metrics

Growth Drivers

Growth Drivers (continued)

Growth Restraints

Growth Restraints (continued)

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Industry Vertical

Revenue Forecast by Region

Forecast Analysis

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Pricing Trends and Forecast Analysis

Competitive Environment

Revenue Share

Competitive Factors Assessment

Competitive Factors Assessment (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Forecast Analysis (continued)

Forecast Analysis (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Forecast Analysis (continued)

Forecast Analysis (continued)

State of the Industry—Present and Future

State of the Industry—Present and Future (continued)

Growth Opportunity 1—Automated Liquid Handling Systems

Growth Opportunity 1—Automated Liquid Handling Systems (continued)

Growth Opportunity 2—Real-time Data Monitoring

Growth Opportunity 2—Real-time Data Monitoring (continued)

Growth Opportunity 3—Insights as a Service

Growth Opportunity 3—Insights as a Service (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

06 Aug 2026   |   Global   |   Technology Research

Decentralized Clinical Trials Powered by Blockchain and Digital Twins

This report examines how decentralized clinical trials (DCTs), enabled by blockchain, digital twins, and artificial intelligence, are reshaping global clinical research. It traces the shift from site-centric to patient-centric models and quantifies the growing scale, globalization, and complexity of...

04 Aug 2026   |   Global   |   Market Research

Global Capnography Devices Market, Forecast to 2031

The capnography market is undergoing a significant transformation from its traditional role in anesthesia and intensive care monitoring to a broader, continuous respiratory surveillance ecosystem. This evolution is being driven by increasing integration of capnography into multiparameter monitoring ...

31 Jul 2026   |   Global   |   Market Research

Growth Opportunities in Small-Molecule Contract Development and Manufacturing Organizations, Global, 2026–2031

The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward s...

30 Jul 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Wearables and Drug Delivery Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, wearables and drug delivery solutions.

The issue features advanced medical devices such as non-invasive bimoda...

30 Jul 2026   |   Global   |   Frost Radar

Frost Radar™: Life Sciences Regulatory Information Management Platforms, 2026

The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical devi...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The pathology workforce shortage, accuracy concerns, and uneven distribution of prices and resources are persistent challenges for the diagnostics sector. Lab test results are the foundation of future human health, influencing 70% of clinical decisions. A surge in lab tests yearly volume will result from persistent trends, including aging populations, growing non-communicable diseases, early-onset cancers, type 2 diabetes, and other cardiometabolic and neurodegenerative diseases. In consequence, advancements in digital technology are steadily expanding the availability of lab diagnostic tools beyond traditional medical settings. The popularity of omnichannel experiences across various consumer digital touchpoints and the rise of mobile apps, online aggregator platforms, and self-care trends (for instance, preventive checks) are boosting the year-over-year (YoY) number of digital users of pathology labs. Certain technologies, such as next-generation sequencing, are shaping the high-end specialized test spectrum, including oncology, prenatal, and infectious disease diagnostics. In this context, a robust business expansion strategy that drives growth while also improving resilience and sustainability is critical for pathology labs looking to expand their business to new markets. Many labs have partnered with in vitro diagnostics vendors to increase access, optimize network organization, and recover lab productivity. These efforts improve test results delivery and generate better-oriented test menus that persist throughout economic cycles. Furthermore, the strategic use of digitization and automation is vital for labs to pivot and grow with changing consumer expectations improved convenience, affordable pricing, and quicker turnaround times. However, incremental upgrades to legacy equipment and workflows may affect digital transformation maturity. Robotic automation and proactive lab monitoring capable of performing intelligent operations are also entering the sector. With a projected 9.1% CAGR, the lab automation and monitoring solutions industry is a significant inflection point in the diagnostics industry. Author: Amartya Bose
More Information
Deliverable Type Market Research
Author Amartya Bose
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Diagnostics lab automation solutions
Keyword 2 Lab monitoring systems growth
Keyword 3 Healthcare automation market
Podcast No
WIP Number PFF5-01-00-00-00